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1. Introduction 
 
Everett Koop has very famously said that for a drug to take effect in a patient it has to 
be taken first and hence if it isn‟t working then the problem could be that it isn‟t being 
taken in the first place.  
 
Diseases or illnesses, implies the need for treatment, either to cure or to alleviate the 
symptoms caused by it. By treatment again the use of pharmacotherapy is inherently 
understood. This is so much truer when considering chronic illnesses specifically. Yet 
studies have shown that even in developed countries about 50% of patients with 
chronic diseases are irregular in their medications(1,2). 
 
This problem has continued down the centuries to become a common challenge of 
current physicians, and has brought with it disastrous consequences as seen in the now 
very common scenario of antibiotic resistance leading to increased use of reserve 
drugs. This problem of irregular treatment adherence also extends towards non 
medication(3) related suggestions such as regular exercise and balanced diet which are 
equally important in establishing good health amongst patients. 
 
In our current century where technological advances have brought about changes in 
treatment that was unimaginable just a few decades ago, medication adherence 
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becomes a serious threat to the quality healthcare outcome. And it is not just the 
patient who suffers by this. The burden is also borne by the relatives or caregivers of 
the patient and the society at large by the economic and social burdens imposed 
inadvertently. Every year about hundreds of billions of dollars are spent for the 
consequences of medication non adherence (4). But that has not been able to stem this 
crisis. And importantly it is money that can be diverted to other important needs or 
requirements, especially so in countries with poor financial resources. 
 
And so it becomes of paramount significance that research be focussed not just on 
seeking newer modes of treating patients, but also on identifying this major problem of 
medication non adherence. And better so if before the problem has arisen rather than 
identifying it after it has happened. 
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2. Review of Literature 
 
2.1 History 
 
Drug non adherence is a challenge that has been faced by physicians since the ancient 
days and has been observed as early back as in the times of Hippocrates when he had 
mentioned in his writings that it was essential to carefully watch on a certain problem 
with patients where they would commonly lie about complying with what was 
prescribed to them. And it was this particular behaviour according to Hippocrates that 
would lead to unfortunate events such as death which could not be justified even if the 
prescribed medication was difficult to take or bitter. 
 
In the past century so much progress has been made in medical science. However 
despite all that, adherence to medications in chronic diseases is still a factor that limits 
the outcome. In chronic diseases the need for complex regimen or the presence of 
severe adverse effects only compounds the problem(5). Non adherence also presents 
itself as a source of bias in clinical research(6). An adherence averaging 50% would in 
a clinical trial increase the require sample size by fivefold as against 100% 
adherence(7).  
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Figure 1: Persistence with secondary prevention medication in the 24 months after 
ischemic stroke in Sweden. Persistent use of secondary preventive drugs declines 
rapidly during the first 2 years after stroke (8).  
 
As a result several studies have looked into the issue of non-adherence in the past few 
decades. The enormous number of studies done, however are of varying 
methodologies and hence unclear at times(9). Different nomenclatures for the problem 
have been used such as compliance, adherence and concordance. The definitions or 
implied meaning for these terms are varied(10) and at times even not defined by 
people undertaking research in the issue(11). Also the use of words such as compliance 
brings with it a negative connotation due to the expected submissiveness of the patient 
to the doctor‟s commands (6). Hence the term adherence would be more appropriately 
used in this context. 
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As difficult as it can be in medical illnesses, the problem of non-adherence appears 
more challenging in the treatment of psychiatric disorders due to various factors which 
includes illness variables and social factors at the least(12). The impact of this is a 
decrease in the quality of life as well as an added burden over the health care 
system(12). Hence the need to stem this crisis is the need of the hour.  
 
2.2 Definition 
 
The World Health Organization defines therapeutic adherence as “the extent to which 
a person‟s behaviour – taking medication, following a diet, and/or executing lifestyle 
changes, corresponds with agreed recommendations from a health care provider.”(2) 
 
Compliance is a word that has been used consistently in this context.  Compliance is 
defined as „The extent to which the patient‟s behaviour matches the prescriber‟s 
recommendations‟ (Haynes, Taylor and Sackett, 1979). However as mentioned earlier 
it does bring a negative aspect towards the therapeutic relationship(9). Due to this 
aspect, the inability of a patient to follow the prescribed suggestion would lead the 
patient‟s behaviour to be interpreted as deviant. 
Adherence is another word that has been used with the same intention(10). It brings 
about a change with the patient also being considered free to decide whether he needs 
to follow the instruction his doctor has provided. And hence modifies the definition as, 
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„The extent to which the patient‟s behaviour matches agreed recommendations from 
the prescriber.‟(11) 
 
Concordance is a newer term that is being used in relation to medication taking. It was 
originally defined as “a new approach to the prescribing and taking of medicines. It is 
an agreement reached after negotiation between a patient and a health care professional 
that respects the beliefs and wishes of the patient in determining whether, when and 
how medicines are to be taken(13). Although reciprocal, this is an alliance in which the 
health care professionals recognise the primacy of the patient‟s decisions about taking 
the recommended medications” (Medicines Partnership, 2001). This was brought up 
with the conceptualisation thatboth the patient as well as the prescriber had a part to 
play in the process of taking medications (Horne, 1993; McGavock, 1996). 
 
However as simple as these may sound, these slight changes of words do bring about a 
significant change. Even the term concordance used is not a word meant to substitute 
the two earlier terms but is rather a process described to change the dynamics in the 
patient physician relationship to more of an equal. But it still does not measure the end 
point of patient behaviour of taking medicines. 
 
In this context it can be also argued that non adherence need not be entirely harmful 
and in some cases may be useful if the prescription was a bad one. This becomes 
clearer in the light of prescriptions being considered as a „therapeutic experiment‟ 
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(Sackett, 1985). Hence the fallible nature of the physician is addressed as well 
highlighting that the physician is also equally responsible for the instructions to be 
followed. 
 
2.3 Types of Non Adherence 
 
Non adherence can be of different types. The first is patients who do not have the 
initial prescription dispensed. The next are who do not present regularly for having 
continued medications. The third lot can be those who do have their medications 
dispensed but do not take them at the dosages that may have been advised. 
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As the above figure indicates these three types of non-adherence can be classified into 
primary, secondary and tertiary. They may also be called as non-fulfilment, non-
persistence and non-conforming respectively.  
 
The impact of non-adherence also varies in clinical scenarios under which a particular 
drug is prescribed wherein certain situations like in the use of oral contraceptives, even 
a single missed dose could change the outcome significantly as against a person with 
dyslipidemia missing his cholesterol lowering drug(12). Also longer acting drugs 
allow a certain deviation in dosing in comparison to a shorter acting drug. This concept 
is understood better in terms of drug forgiveness, which is arrived at by subtracting the 
dosing interval from the duration of action(14). 
 
The figure below illustrates the approximate percentages of various consequences after 
a prescription has been filled in. Of 100 prescriptions filled only about 50-70 actually 
go to a pharmacy. And only 25-30 actually take them properly while only 15-20 refill 
them as prescribed (14). That points out to a huge problem in the system despite 
various measures being implemented by organisations world over to address this issue. 
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Figure 3: Gap between prescription and medication use.(14) 
2.4 Prevalence 
 
2.4.1 Psychiatric illnesses in children and adolescents outside India 
 
The prevalence of any ICD-10 diagnosis among a random sample of 5-10 year old 
children in Bangladesh were found to be at 15% with an increased rate of obsessive 
compulsive disorders as well as increased prevalence of behavioural problems among 
slum children (15). This study concluded that based on these figures about 5 million 
children by virtue of extrapolation have psychiatric disorders and in a country with 
For every 100 
prescriptions 
written 
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very few child psychiatrists there would be a significant gap between what was needed 
and what was available. 
 
2.4.2 Non adherence in Medical illnesses outside India 
 
As mentioned previously WHO estimates that about 50% of patients with chronic 
diseases are irregular with their medications(2). In fact a recent article mentioned that 
the problem of non-adherence costs Americans between 100-280 billion US dollars 
annually(16). Similarly the problem of non-adherence amongst Europeans has been 
estimated to cost the EU about 1.25 billion Euros annually(17). 
 
In a study conducted in Nigeria about 41% of the participants reported themselves to 
be non-compliant with their anti hypertensives(18). Another study in Ireland showed 
about 18% to be consistently non adherent to medications prescribed(19).  
 
2.4.3Non adherence to medications in Psychiatric illnesses outside India 
 
Ghaziuddin et al (20), in a study conducted to assess the prevalence as well as 
predictors of non-compliance in adolescents with psychiatric disorders found that 
33.8% were non adherent. They also concluded that it was a relatively common 
problem and a difficult one to predict. 
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In a study by Pogge et al conducted in the U.S, among 86 adolescent psychiatric 
inpatients, following discharge at 10 months only about 45% were adherent to the 
prescribed medications(21). Another study conducted in Brazil, which focussed on 
victimized children, those children who had mood disorders alone were found to have 
higher rate of adherence of 79.5%. Those with substance abuse disorders alone had 
poorer compliance at 40%. An intermediate rate of 50% was observed among those 
having both disorders(22). 
 
2.4.4 Psychiatric illnesses in child and adolescent population in India 
 
Generally data on mental needs of children in India are limited(23). The Indian 
Council of Medical Research conducted an epidemiological study to study the 
prevalence rates of psychiatric disorders in child and adolescent population. This was 
conducted in two centres, namely Bangalore and Lucknow. At Bangalore about 2064 
children aged less than 16 years were studied which showed a prevalence rate of  
psychiatric disorders in child and adolescent population to be at 12.5%(23). 
 
In another study conducted at Chandigarh involving school children aged between 4-
11 years, about 6.33% were found to have an ICD-10 criteria based psychiatric 
disorder when assessed by a psychiatrist after initial screening by parents and teachers. 
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Estimates by teachers of the prevalence rates were higher at 10.17% as compared to 
estimates of parent‟s at 7.48%(24). 
 
A follow up study to the Chandigarh study which looked at the incidence of 
psychiatric disorders in children revealed an incidence of 18 per 1000. However the 
authors also suggested that the higher dropout rate in the study could have resulted in a 
lower than expected results(25). 
 
2.4.5Non adherence in Medical illnesses in India 
 
Adherence to anti TB medications in developing countries has been reported at 
40%(26). In a cross sectional study conducted in Mumbai about 84% of patients were 
adherent to the DOTS scheme(26). In another study conducted among diabetics in 
Dehradun only 16.6% were adherent to the prescribed medications while only 23.3% 
were adherent to the prescribed dietary restrictions(27). 
 
According to the APA, about 50% of children with chronic medical conditions are 
found to be non-adherent with their prescribed treatment(28). Studies done have 
revealed that non adherence among children with chronic medical conditions have 
resulted in increased health care use(29).  
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2.4.6 Non adherence in psychiatric patients in India 
 
Among psychiatric patients about 50% and 75% are non-adherent by the end of the 
first and second year respectively(30). In a study conducted among schizophrenia 
patients followed up at a centre in Chennai, about 58% reported non-compliance at 
some point of their treatment course(31). 31% of schizophrenia patients who attended 
a walk in clinic in India did not follow through for further detailed evaluations while 
another 32% would not turn up for follow-ups after the detailed evaluation (32).  
 
Also about 10-60% of patients on treatment for depression were likely to discontinue 
their medications(33). Whereas among those patients on treatment with mood 
stabilisers, between 18-52% were non adherent(34). In comparison to non-depressed 
patients, depressed patients were found to be 3 times more likely to become non 
adherent to their medications(35). 
 
Other Indian studies looking into prevalence of non-adherence give widely varying 
results. In a study which looked into people with mental disorders, 50% of whom were 
suffering from schizophrenia, non-adherence was observed in about 38% of those 
studied(36). 
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In a study conducted at a tertiary care hospital in Kolkata, nearly 67% of 239 unipolar 
depressive patients were non adherent with their medications(37). This led them to 
relatively requiring more medications in comparison to those patients who were 
adherent to their prescribed treatment. 
 
In another tertiary care centre in Chennai, a study done over 8 months among 200 out 
patients diagnosed with a psychiatric illness by a psychiatrist revealed that more than 
80% of the assessed patients were non adherent with their medications(38).  
 
In a cross sectional study done at IMHANS (Institute of Mental Health and 
Neurosciences) in Srinagar, only 26% of 200 patients were non adherent. The study 
was done from 2011 to 2012 with a newly designed questionnaire among out patients, 
while excluding new patients.  
 
2.4.7 Non adherence in children and adolescent psychiatric population in 
India 
 
The problem of medication non adherence is equally present in paediatric 
populations(39). A study by Costello et al have suggested that in comparison to adults, 
it may be worse in children and especially so in adolescents(40). This occurred across 
all conditions and required significant efforts from caregivers to balance concerns of 
medications versus the concerns of the illness(41) 
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Overall there was a paucity of data studying adherence of medications among children 
with psychiatric disorders in India. In a study by Sitholey et al conducted at Lucknow, 
among 24 children newly diagnosed with ADHD, 83.3% were non adherent within a 
month(42). 
2.5 Factors 
 
According to the WHO factors related to non-adherence fall mainly under 5 domains. 
These are patient related, condition related, therapy related, health system related and 
socioeconomic factors(2). 
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Understanding this model helps in directing specific solutions under those specific 
factors in a more focussed manner. It is easier for the physician to elicit or clarify for 
reasons if medication non adherence is suspected for the poorer outcome than 
expected. 
 
Patient- related factors are those which occur due to a reduced understanding of the 
disease as well as its complications. Therapy related factors are chiefly related to the 
failure by the treating doctor to recognize noncompliance and prescription of complex 
drug regimens. Any solution to improve adherence can be considered only when all of 
these factors are taken into consideration.  
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 Figure : Reasons cited for medication Non adherence (43) 
 
 
Figure : Issues related to provider-patient communication, physician interaction with 
the health care system and patient interaction with the health care system (44) 
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We will now look at a few factors that have an impact on medication adherence 
keeping in mind the score card that is being validated in this study.  
2.5.1 Gender 
 
Gender is a factor that can have a bearing on the adherence pattern towards 
medications.  This is especially more so if the said condition is for a behavioural 
disorder (45). In a study conducted in the United States among 29.5 million adults, it 
was found that women were more likely to adhere to their medications (46). 
 
2.5.2 Education 
 
Education is a factor that has been looked into and found to be associated with 
medication adherence behaviours. In a study conducted in Pakistan among diabetic 
patients, it was found that maternal education had a significant relationship with 
medication adherence (47). However the direction of this significance was not clearly 
stated. A similar finding was echoed in a study done in Tanzania, again among diabetic 
patients (48). In this study it was observed that educational status of the care giver had 
association with medication adherence. 
 
In yet another study conducted in south west Nigeria it was observed that primary 
school education was associated with higher self-reported compliance in patients being 
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treated for hypertension(18). A study in Finnish adolescents with epilepsy showed that 
good parental support had a positive effect on medication adherence (49). This could 
possibly be associated with the parental education though not specified so. 
 
However there are studies that show an opposite trend also with people of lower 
educational status showing better compliance(50). In a review article published in 
2008, it was found that the effect of educational status on medication adherence being 
equivocal (51). 
 
2.5.3 Socio Economic Status 
 
Treatment implies a cost that has to be borne by the patient for a period ranging from a 
few days to lifelong. Studies have found that this cost can be a reason for many to 
poorly adhere to their medications (52). Especially so in case of patients with chronic 
diseases, cost of treatment can be a burden if their income is inadequate or they have 
nil or low insurance support to meet their needs (53). 
 
In a study conducted among hypertensive patients it was found that between 30-46% 
of patients were poorly adherent to their prescribed medications. The survey was 
conducted by chart reviews as well as telephonic interviews. It was noted that 
employment and cost were factors that were associated with non-adherence(54). 
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Dutta et al in their study looking at socio-demographic factors for non-compliance to 
treatment, in patients with locally advanced cervical cancer being treated at a rural 
medical college in West Bengal, found not surprisingly that poor socio economic 
status was the second most common factor for non-compliance(55). 
 
In another study conducted among patients with affective disorders who were 
prescribed Lithium carbonate, poor adherence was associated with patient‟s 
perceptions of the cost involved. This study considered adherence to be defined by 
serum lithium level within a recommended therapeutic range and attendance for a 
period of six months prior to the study at 75 per cent or more of regularly scheduled 
clinic appointments (52).  
 
Also about 10% of patients reported costs as a reason for non-compliance towards 
inhalers in patients with bronchial asthma. This was in a study conducted at 2 medical 
colleges in Karnataka in the respective department of respiratory medicine following 
up patients over a 2 year period (56). 
 
2.5.4 Type of Illness 
 
The duration of the illness remains another crucial factor related to medication 
adherence. Acute illnesses are known to have a better adherence than with chronic 
illnesses (57). In a study among tuberculosis patients, it was noted that while 
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comparing the adherence rates of different durations of treatment of 3, 6 and 12 
months, adherence rates were higher for shorter durations at 87%, 78% and 68% for 
the three regimens, respectively (57). 
 
However certain other studies such as by Sharkness et al showed that over the years 
the adherence rate improved due to probable improvement of patients denial and a 
better understanding of the illness and need for treatment (58). 
 
2.5.5 Nature of Illness 
 
Sultan et al in their recently conducted study in 2013 in a medical college in Andhra 
Pradesh, amongst out patients over a period of 7 months, concluded that the presence 
of continuous illness like schizophrenia resulted in an increased rate of non-
adherence(59). About 45% of patients with schizophrenia in their study were non 
adherent to their prescribed medications. The reason attributed for this was a lack of 
understanding of the illness. 
 
A similar finding was echoed by Pareek et al who in their study concluded that the 
presence of a chronic illness requiring long term treatment was cited by caregivers of 
patients as a reason for the problem of non-adherence(60). 
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2.6 Measuring Non Adherence 
 
There are several ways to assess medication non adherence (61). These would include 
both subjective as well as objective measures. Subjective measures used would include 
eliciting history from the patient as well as the caretaker, checking patient‟s case note 
recordings, looking into prescription dispensing, as well as the treating physicians own 
assessment of the patients medication taking behaviour. 
 
Among these the patient self-report is reported to be most accurate (63) and was also 
seen to be comparable to of another study assessing medication non adherence in 
mood disorders (33).  In a study conducted in Canada it was found that physicians 
were unable to predict the medication behaviour in more than 70% of their patients 
despite having known them for several years (64).  
 
Adherence can also be measured by collateral information gathered from family 
members, pharmacists as well as by methods such as pill counting and estimation of 
drug levels in the blood. We shall look into the challenges of these methods in the 
following paragraphs. 
 
Though self-reporting has been found to be a good method of assessing medication 
non adherence (65), asking patients for their drug taking history can be beset with 
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problems where the patients can claim to be on regular medications which would 
however be countered by alternate methods used to confirm such as counting of pills 
as was seen in the study done among a group of patients with affective disorders (33). 
There could be both decreased as well as increased doses being taken. 
 
Figure: Comparison of varying adherence rates by using different methods in the same 
patient (66) 
This study (67) looked into the various adherence rates obtained using various 
methods. They came to a conclusion that adherence may be better represented by a 
composite score while it was underestimated by using MEMS (medication event 
monitoring system) and overestimated by direct interview and pill counts. 
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The problem of inaccuracy in self-reporting may occur due to patients facing the 
challenge of being honest with their treating physicians of their drug taking behaviour 
and thereby causing them displeasure or being embarrassed (66). Or in other cases 
could be due to plain unawareness. 
 
Though the help of the family members may be roped in dealing with the problem of 
non-adherence, it is physically impossible to do so all the time. There could also be the 
physician increasing the risk of strained relations between the patients and their family 
members. 
 
Counting of pills is the other method that can be used. But again there can be instances 
when pill numbers may tally with the patient secretly discarding the medications to 
avoid getting caught. Or it may also occur that the patient may not be taking doses in 
the manner prescribed(68). 
 
Biochemical evidence of medications(69) being adhered to, through assessing the 
blood or urine, though reliable may not be cost effective on a regular basis as well as 
again damages the therapeutic relationship between the patient and the treating 
physician. Also it may not reflect whether the accurate dosing is being taken or even 
prescribed and may just say whether the drug was taken or not. There may also be 
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drugs which cannot be estimated by such methods or even individual variations of 
absorption and/or metabolism of drugs in patients especially so in extremes of ages. 
 
All of this suggests that there is not a single way by which medication non adherence 
can be surely identified. And it would be rather a combination of methods that would 
serve to identify the problem. 
 
For certain patients the taking of medications would be a stark reminder of the fact that 
they have an illness. Hence denial would be a reason for such people to be non-
adherent to their medications (70,71).  
 
A physician who is perceived to be rigid and cold in his dealings may not go well with 
patients who expect a friendlier and warm person to help them with their medical 
problem. And this could also cause difficulty in maintain adherence to medications. 
 
Even simple measures improving patients satisfaction with the care provided such as 
reducing the waiting period for or understanding and responding according to the 
patients cultural values is found to influence medication adherence positively (72) 
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And so the challenge to researchers has been as to how to measure adherence to 
medications has remained (73). And the lack of a valid method to measure non 
adherence itself has been a stumbling block in medication adherence research. 
 
Direct methods of measuring medication adherence are considered to be the most 
representative of truth. However to many patients this would be unacceptable being 
invasive. Besides this may be feasible in situations of a single dosing, intermittent 
medications or in hospitalised patients (73). 
 
With the advent of microprocessors and the use of electronic devices, or MEMS 
(medication event monitoring system), which enables both frequency and time of 
opening of the medication bottle to be measured (73), there have been startling 
discoveries of „drug holidays‟ and „white coat adherence‟. This was when the patient 
would become compliant towards the time of the consultation time (67). 
 
Though methods such as electronic monitoring may be used to enhance adherence, if a 
patient did not intend to be adherent then he/she would not make the effort to use an 
electronic dispenser in an expected manner(74). 
 
Now we will look into various measures used to assess medication non adherence.  
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2.6.1 Morisky Medication Adherence Scale – 8 
The original Morisky scale was a 4 item scale that was a self-reporting questionnaire 
with dichotomous answering (75). It was developed in 1986 and validated in a setting 
of patients on antihypertensive medications. It was based on the premises of drug  
errors which could occur in 4 different ways. It could be due to the patient simply 
forgetting or maybe due to a carelessness regarding adhering to prescribed schedule or 
stopping and starting the drug when based on feeling better or worse(76). It had a 
sensitivity of 81% and specificity of 44%.  
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Table: Comparison of MMAS-4 and MMAS-8 
In 2008 it was further modified into an 8 item questionnaire with the first 7 questions 
maintaining the dichotomous pattern, while the eighth and final question was a 5 point 
likert type question. This improved the sensitivity to 93% and the specificity to 53%. 
This is now a widely used tool for assessing medication non adherence.  
 
 
 
Table: Scoring ranges for MMAS-4 and MMAS-8 
The researchers, who developed the MMAS-8 while working among hypertensive 
patients, proposed that the tool was a very simple one to use in practical situations like 
an outpatient setting and was therefore a relevant tool to aid in identifying patients 
with medication non adherence (77). 
 
The qualities that make it a preferred tool include it‟s validation into several languages 
across the world, it‟s use in different settings and diseases (75). In a study conducted in 
Brazil among hypertensive patients it was found that the MMAS-8 translated into 
Portuguese was a valid tool to help in identifying medication non adherence and there 
was a significant relationship between MMAS-8 scores and Blood Pressure control 
(78). 
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However the MMAS-8 is not a comprehensive measure and only captures non 
adherence in certain areas (77). It also is unable to predict or assess reasons towards 
non adherence. And so by this lacking makes it less useful in applying interventions to 
address such factors.  
 
Another drawback is that it is only able to measure adherence to medications in one 
particular disease. Several patients may be on prescriptions warranting them to be on 
multiple medications at the same time. However due to personal reasons or beliefs they 
may be selective in following the prescribed order and be adherent to some 
medications while being non adherent to certain other medications (75). 
 
However despite these limitations the MMAS-8 is a good screening tool that can be 
used as an aid to identify patients who may be non-adherent to their medications. It has 
been used across several countries by researchers as well as physicians across various 
settings and populations to aid in their respective work in relation to medication non 
adherence. And so we have chosen this as a measure for calculating predictive 
accuracy in this particular study. 
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2.6.2 Clinician Rating Scale 
 
The Clinician Rating Scale is a simple ordinal scale of 1-7 that helps a physician or 
researcher to quantify his/her assessment of the patient‟s extent of medication 
adherence(79). According to this scale higher scores would point towards greater 
medication non adherence. Scores of < 5 were considered to be non-adherent(80). 
 
The CRS has shown to be sensitive in two controlled trials looking at compliance 
therapy where it demonstrated differences in outcome in patients who were receiving 
compliance therapy as against a non-specific counselling (81,82). 
 
In this researcher‟s study the CRS is being used as a measure of gold standard to 
determine the sensitivity and specificity based cut offs. 
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3. Diagnostic Accuracy Studies 
 
In our present research we aim to validate a newly developed score card. So let‟s now 
look into the relevant aspects of what validation means and its relevance to research. 
Validation involves the testing as well as the adaptation of instruments that measures 
patient related outcomes where it has not been tested yet. This would fall into the 
category of diagnostic accuracy studies, which are designed to gather evidence on how 
well would a particular test identify or even rule out a particular disease or a condition 
(83). 
 
In the present day clinical practise the use of tests is an absolute necessary right from 
diagnosing a disease(84) to prognosticating it as well as assessing the response to 
treatment. And so in such a situation the need for the particular test to be able to 
produce as well as reproduce what it intends to is of paramount importance. The agony 
that the patient goes through in being diagnosed falsely positive to a critical condition 
or the harm that awaits a patient who has been deemed to be falsely negative to a 
condition cannot be quantified by words. Hence the need for assessing and 
understanding the properties of a particular study, at a specific threshold, as to its 
sensitivity and specificity or even its positive or negative predictive value is very 
relevant.  
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It would be ideal when comparing two diagnostic tests that they be compared in the 
same patient. If that would not be possible then at least they ought to be from the same 
randomized population. This would ensure that the difference observed would be due 
to the tests and not to the patient (83). 
 
3.1 Sensitivity and Specificity 
 
Certain methods would summarise the so called accuracy of a study at over a range of 
different thresholds. These would summarise the accuracy over a range for example as 
the area under the receiver operator curve (ROC).If a diagnostic accuracy test is to be 
clinically useful, it should help in influencing the management of the patient.  
 
 
 
 
 
 
 
Fig: ROC plot showing excellent, good and worthless curves (85) 
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The term sensitivity of a test refers to the ability of the test to identify a positive 
finding when the targeted condition is actually present. This is also referred to as true 
positive. In other words, it is the ability of the test to identify a condition in a person 
when the condition is actually there. 
 
The term specificity refers to the ability of a test to identify if the disease or condition 
is absent when in actuality it is truly is absent. This is also referred to as true negative. 
These values can be used to arrive at likelihood ratios, both positive and negative. In 
simpler terms this would mean the ability of the test identify those people as not 
having the condition when it is actually absent. 
 
3.2 Errors 
 
There also is the need for proper evaluation process in such studies, to reduce the rate 
of errors(86). Poorly designed studies may lead to diagnosis being inaccurate, 
treatment being inappropriate as well as errors of judgement while making clinical 
decisions. Poor methodological issues may lead to poor quality of reporting (87). 
 
Some reasons for such shortcomings in methodology include poor reference standard, 
selection bias, absence of rater blinding insufficient definitions for positive negative 
and indeterminate findings (88). 
48 
 
Diagnostic accuracy studies may be done for a newly developed instrument or it may 
also be applied in new diseases where it may not have been applied yet or even in new 
populations or languages. This also involves test retest reliability, internal consistency 
as well as validity.  
 
This process involves comparing the new test with another which would be the gold 
standard and verifies whether the new test will be able to produce desirable results in 
comparison. This construct is referred to as validity (89). 
 
It needs to be understood that validity is distinct from reliability. While validity refers 
to whether the desired test measures what it sets out to measure originally, reliability 
refers to whether the test does so consistently. So putting into perspective, if a clock 
was unable to show the time it would be invalid. However, if it was on certain 
occasions slow and on other occasions fast it would be deemed to be unreliable. If a 
clock was consistently 30 minutes slow then it would be reliable but not valid. 
 
3.3 Convergent and Divergent Validity 
 
Another aspect to be kept in perspective while understanding validity is its two facets. 
These are referred to as the convergent and divergent validity. By proving the presence 
of both  test is deemed to have a valid construct (90). Convergent validity refers to the 
49 
 
strength of association between independent measures which are designed so as to 
measure the same construct. Whereas divergent or discriminant validity refers to the 
poor association between measures that are designed for unrelated constructs (89). 
 
For a measure with good construct validity, attempts must begin right from the initial 
stage when the construct is defined and various factors are considered to be 
representative (89).  So if a test would have to measure for example psychosis, then the 
crucial first step would be to define what psychosis would be. In the absence of a 
precise definition there would be difficulty in distinguishing it from say anxiety or 
depression.  
 
Messick in his work described that construct validity had six contributors; content 
relevance and technical quality, theoretical understanding of scores and associated 
empirical evidence, structural data, generalizability, external correlates and  
consequences of score interpretation(91). 
3.4 Diagnostic Accuracy Studies in Non-Psychiatric Patients 
 
The relevance of such studies occur in the light of the fact that despite the presence of  
gold standard tests, newly developed tests may serve some benefit such as being a 
cheaper alternative or as a screening tool. It could also be less invasive or simpler.  
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In a study conducted in the United States, a newly developed prospectively applicable 
method for aiding in the classifying of co morbid conditions which could change the 
risk of mortality in longitudinal studies was conducted and was found to be simple, 
readily applicable as well as a valid method of doing so (92). 
 
In another study conducted among general medical populations, the validity as well as 
the reliability of 3 scales was assessed and found to be internally reliable. It was able to 
look into the reason behind health care utilisation by the general population (93). 
 
The Brief Pain Inventory is a scale which is used to assess pain in patients who were 
having malignancy. It was a simple tool that could be used in patients for palliative 
care. This was validated into the German language and was found to be comparable to 
the original version (94).  
 
Tan et al in a study conducted among patients with chronic intractable non-malignant 
pain used this scale, which was primarily used for assessing pain in patients with 
malignancy. Though this tool was translated into different languages this was the first 
time that it was being used for a different indication (95). As a result they were able to 
validate the instrument for a new indication. 
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3.5 Diagnostic Accuracy Studies in Psychiatric Patients 
 
In a study conducted in the state of Kerala under the National Rural Health Mission 
(NRHM) a self-administered questionnaires for assessing mental health among 
adolescents in primary-care setting was validated (96). It was the shorter version of the 
Teen Screen Questionnaire-Mental Health (TSQ-M). The study revealed the shorter 
version which was newly developed had for a score of ≥ 6 ,a sensitivity of 76%, 
specificity of 74%, positive likelihood ratio of 2.99, negative likelihood ratio of 0.33, 
positive predictive value of 6% and a negative predictive value of 82.1%. This was 
better than the original scale (96). 
 
In another study conducted in a tertiary care centre in Tamil Nadu, Russell et al 
evaluated the diagnostic accuracy, reliability and validity of Childhood Autism Rating 
Scale (CARS) (97). The authors assessed that a score of ≥33 in the CARS achieved a 
sensitivity of 81.4% (95% CI=71.6-89), a specificity of 78.6%, (95% CI=49.2-95.1), a 
positive likelihood ratio of 3.8 (95% CI=2.8-5.1), a negative likelihood ratio of 0.24 
(95% CI=0.08-0.70), a positive predictive value of 95.9%, and a negative predictive 
value of 40.7%; therefore it was ideal as a screening cut-off score to identify possible 
cases of autism (97). 
 
In a study by Mona et al the Beck‟s Depression Inventory (BDI) was studied for the 
diagnostic accuracy, reliability and validity when used by paediatricians (98). The 
authors observed that a cut-off score of ≥ 5 had a sensitivity of 90.9% and specificity 
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of 17.6 % for screening. With a cut-off score of ≥ 22 the sensitivity was 27.3% and 
specificity 90% for diagnosis. They concluded that it was a psychometrically valid tool 
for screening depression in adolescents in a primary care setting (98). 
 
In yet another study a Sinhalese translation of the Impact of Event Scale- 8 items 
version (IES-8) for use in Sri Lanka was validated (99). This was a cross sectional 
study that was conducted in rural south Sri Lanka to survivors of the tsunami. A cut-
off score of 15 gave a sensitivity of 77% for screening purposes. 
 
Mammen et al developed and validated a concise, parent-completed Brief Intellectual 
Disability Scale (BIDS) for children to be used in countries with low–disability 
resource and high–disability care burden (100). It was a prospective cross sectional 
study. They concluded that BIDS scores of ≥5 had sensitivity of 71.43% and 
specificity of 80.95%, while scores of ≥11 had sensitivity of 4.29% and specificity of 
100%. 
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3. Justification 
 
The problem of medication non adherence is significant in terms of the impact on the 
patients, their families and the larger society. Currently there are no standard measures 
or tools to predict the possibility of non-adherence in a patient. The available tools 
only help in assessing the problem after it has happened. A standardised tool to predict 
this problem would help in implementing specific measures and strategies before the 
non-adherence actually occurs and saves resources as well as prevent unnecessary 
distress to patients and their families. 
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4. Aims and Objectives 
 
4.1 Aim 
 
The aim of this study is to evaluate the predictive validity of a newly developed score 
card to assess medication non adherence in children and adolescents with psychiatric 
disorders attending a tertiary care hospital in Vellore. 
 
4.2 Objectives 
 
1. To measure the predictive ability of the score card by comparing with the gold 
standard test after a period of 3 months  
2. To measure the convergent and divergent validity of the score card 
3. To assess the inter rater reliability of the score card 
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5. Materials and Methods 
  
5.1 Setting and Participants 
 
The setting for the study was the Child and Adolescent Psychiatry Unit, Department of 
Psychiatry, Christian Medical College, Vellore. This is a tertiary care centre in South 
India without any geographically defined catchment population. The unit has two 
divisions, one for children with emotional and behaviour problems and the other for 
children with developmental disorders. The study included children from both the 
divisions. The study was conducted from January 2015 till the sample size is achieved. 
 
5.2 Study Population 
 
The study population in this study was children with emotional or behavioural 
disorders who enrolled for out-patient review consultation and management in the 
Child and Adolescent Psychiatry Unit. Those participants who satisfied the selection 
criteria formed the study sample. 
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5.3 Sample Size 
 
 
 
 
 
 
 
  
 
 
 
 
Required sample size to show that the new tool is able to show non-adherence was 
found to be 150 children, with 80% power and 5% level of significance and a 
prevalence of about 20% of non-adherence. 
 
Regression methods - Multiple  logistic regression  
Proportion of disease  0.5 0.2 0.5 0.2 
Anticipated odds ratio 2 2 1.5 1.5 
Power (1- beta) % 80 80 80 80 
Alpha error (%) 5 5 5 5 
1 or 2 sided 2 2 2 2 
Multiple correlation coefficient of the 
exposure variable with the confounders  0.3 0.3 0.3 0.3 
Required sample size 99 149 229 383 
      
Sample size  150   
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5.4 Selection Criteria 
 
5.4.1 Inclusion Criteria: 
1) Age between 3 and 18 years of age.  
2) Those with various psychiatric disorders according to International Statistical 
Classification of Diseases and Related Health Problems 10th Revision.  
3) Those who are on psychotropic medications.  
4) Patients who are attending the new or review outpatient clinic in CAP unit.  
5) Either the patient or the primary caregiver should have a working knowledge of 
Tamil and English.  
 
5.4.2 Exclusion criteria: 
1) Those who are not accompanied by a reliable caregiver to give medication 
adherence history.  
2) Those children unwilling for a written informed consent by the parent.  
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5.5 Sampling Technique 
 
All consecutive patients who are registered under the Child and Adolescent Psychiatry 
unit and who satisfy the selection criteria will be recruited into the study. 
5.6 Study Design 
 
This is a prospective longitudinal study where the Vellore score card was validated. 
 
5.7 Measures 
 
5.7.1 Vellore Score Card for Adherence to medications 
 
This is a score card for medication non adherence developed in the Child and 
Adolescent Psychiatry Department at CMC Vellore. The score card building was based 
on the odds ratio (OR) and the clarity of the „predictiveness‟ by being picked-up by 
more than one measure for the medication adherence. The OR was taken as a „risk 
factor‟ if it was >1 and as „protective factor‟ if it was <1. Each risk factor was given 
the same weightage as the OR but was rounded to the decimal. However, for the 
protective factors for each 0.25 reduction in the OR a score of 0.25 was given. The 
score card is given below. 
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5.7.2 Comparing other tools for medication adherence 
 
Given below in the table are various the tools used for measuring non adherence to 
medication. 
 
Scale Author Sensitivity Specificity 
MMAS Morisky 93 53 
CRS Kemp NA NA 
MAQ Morisky 81 44 
BARS Byerly 73 74 
MARS Thomson NA NA 
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Table: MMAS – Morisky' Medication Adherence Scale; CRS – Clinician Rating 
Scale; MAQ – Medication Adherence Questionnaire; BARS – Brief Adherence 
Rating Scale; MARS – Medication Adherence Rating Scale 
 
The MMAS and CRS have been discussed earlier. The MAQ was originally developed 
by Morisky and his colleagues towards assessing medication adherence. This was done 
in a population of hypertensives and shown to have good predictive validity. It has 
been used by several researchers as well. However psychometric analyses have shown 
only mixed results (101). 
 
The BARS was developed by Byerly and colleagues(102). It was introduced with a 
simple description of a clinical rating scale for adherence that could be done with 
merely a pencil and a paper. It consisted of only 3 questions which was adapted from a 
questionnaire which was used in the CATIE trial. These questions assessed the patients 
knowledge about his medication patterns. The adherence was finally measured via a 
visual analogue scale. 
 
The MARS was developed by Thomson and his colleagues which incorporated 
features from the MAQ and another scale called the Drug Attitude Inventory (DAI) 
(103). It was proposed to have a better validity and clinical utility. It consisted of a 
simple 10 item questionnaire.  
61 
 
As there is currently no measure that is considered as a gold standard test for 
measuring non adherence, we have decided to consider the CRS scale as the gold 
standard test in our study. 
 
5.7.3 Kuppusamy Socioeconomic Scale 
 
In our study we have used the Kuppusamy socioeconomic scale modified for the year 
2014 by Sukhvinder Singh Oberoi(104)for the purpose of measuring socioeconomic 
status. 
 
Education Score 
Professional or Honours 7 
Graduate or Postgraduate 6 
Intermediate or post high school diploma 5 
High school certificate 4 
Middle school certificate 3 
Primary school certificate 2 
Illiterate  1 
Occupation Score 
Professional  10 
Semi professional 6 
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Clerical, shop owner, farmer 5 
Skilled worker 4 
Semi-skilled worker 3 
Unskilled worker 2 
Unemployed  1 
Monthly family income Score 
≥36,997 12 
18,498-36,996 10 
13,874-18,497 6 
9,249-13,873 4 
5547-9248 3 
1866-5546 2 
≤1865 1 
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Based on the above scoring system the scores for various socioeconomic classes are as 
follows. 
 
Socioeconomic Class Score 
Upper class 26-29 
Upper middle class 16-25 
Lower middle class 11-15 
Upper lower class 5-10 
Lower class <5 
 
 
5.7.4 Child Sleep Habits Questionnaire 
 
This questionnaire is used in the present study to assess the divergent validity of the 
score card.Following are a few relevant details regarding its development and use. 
 
The Child Sleep Habits Questionnaire was developed in the United States as a 
screening tool for measuring sleep disorders in children (105). It is a parent based 
report for school children(106). It gives a total score as well as eight subscale scores 
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that cover significant sleep domains in children. This includes both medical as well as 
behavioural sleep disorders.  
 
The eight subscales include bedtime resistance, sleep-onset delay, sleep duration, sleep 
anxiety, night wakening, parasomnias, sleep disordered breathing and daytime 
sleepiness (105). The items under each of these are score on a 3 point scale. 
Accordingly a higher score indicates sleep pathology. A cut off score of 41 has a 
sensitivity of 82% and specificity of 72% (106). 
 
The CSHQ is a well validated tool that has been used in different countries and has 
been translated into several languages.  
 
5.8  Interview and Assessment 
 
All children and adolescents attending the review OP clinic of Child and Adolescent 
Unit, during the study period starting from January 2015, till the sample collection 
calculated a priori was completed, was enrolled in to the study if they fulfilled the 
selection criteria. At the time of enrolment the Score card followed by the CRS, which 
was the gold or reference standard and CSHQ measures for divergent validity was 
administered by Rater 1. Simultaneously about 20% of the children was administered 
the score card by Rater 2 to collect the data on inter-rater reliability. After 3 months the 
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measure for predictive validity the MMAS-8 was administered by Rater 3. At this 
time, Rater 1 reassessed 20% of the children with the score card for collecting the data 
on the test-retest reliability. 
The detailed diagrammatic algorithm for the study was as follows. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 patients approached who 
satisfied selection criteria 
43 consented 
Score card, CRS and CSHQ 
administered to 43 and score 
card repeated for 6 
MMAS administered to 14 and 
repeat score card for 8 
Missing data for 2. Analysis 
done for 41 
Results and conclusion 
Baseline 
At 3 months 
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5.9Statistical Analysis 
 
The frequencies and percentages for the categorical  variables which were the age, 
duration of illness, duration of treatment, number of classes of medications and the 
distance of home from the hospital was calculated. Mean with standard deviation was 
calculated for continous variables which were gender, religion, socioeconomic status, 
diagnosis, co morbid illnesses, family type, parent education and parent occupation. 
The inter rater and test retest reliability of the new tool was calculated using Intra class 
Coefficient Correlation. Diagnostic accuracy of the tool was determined by ROC 
analysis and contingency tables. The cut off points for identifying the cases was 
obtained by plotting ROC curve with the CRS tool as the reference standard.. The 
divergent validity was done by using Pearsons correlation in comparison with the child 
sleep habit questionnaire (CSHQ). Chi square analysis and kappa value was obtained 
for measuring the predictive value of the Scorecard using the dichotomised Vellore 
score card and the MMAS -8. Factor validity was derived using factor analysis which 
was done by Extraction and Rotation method to look into the correlation between the 
variables of the Vellore score card 
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6. Results 
 
The results will be discussed under the following headings of participant 
characteristics, diagnostic accuracy, reliability of measures used and the validity of 
score card. 
About 48 patients who met the selection criteria were approached initially. Among 
these only 43 consented to the study. Among the 43 who consented 2 had missing data 
and so were excluded from the final analysis.  
6.1 Sociodemographic data 
 
Table1: Patient and family characteristics for the sample 
Variable Frequency (percent) 
Sex 
     Male 
     Female 
 
29 (70.7) 
12 (29.3) 
Religion 
     Hindu 
     Muslim 
     Christian 
 
37 (90.2) 
2 (4.9) 
2 (4.9) 
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Socioeconomic status 
     Upper class 
     Upper middle class 
     Lower  middle class 
     Upper lower class 
 
3 (7.3) 
4 (9.8) 
12 (29.3) 
21 (51.2) 
Diagnosis 
     Acute Psychosis 
     Schizophrenia 
     Depression 
     BPAD 
     OCD 
     Adjustment disorder 
     Enuresis 
     ADHD 
     Intellectual Disability 
     Autism 
 
1 (2.4) 
5 (12.2) 
4 (9.8) 
4 (9.8) 
4 (9.8) 
2 (4.9) 
1 (2.4) 
2 (4.9) 
15 (36.6) 
3 (7.3) 
Co-morbid conditions  
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     No Co morbidity 
     Depression 
     ADHD 
     Intellectual Disability 
     Seizure disorder 
31 (75.6) 
3 (7.3) 
4 (9.8) 
2 (4.9) 
1 (2.4) 
Parent education 
     Illiterate 
     Primary school 
     Middle school 
     High school 
     Intermediate/diploma 
     Graduate or post graduate 
     Professional or honours 
 
2 (4.9) 
4 (9.8) 
2 (4.9) 
20 (48.8) 
7 (17.1) 
4 (9.8) 
2 (4.9) 
Family type 
     Nuclear 
     Joint 
     Extended 
 
15 (36.6) 
9 (22) 
3 (7.3) 
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Table 2: Patient and family characteristics for the sample contd... 
Variable Mean (std deviation) 
Age in years 11.8 (4.75) 
Duration of illness in months 49.44 (41.11) 
Duration of treatment in months 20.37 (15.03) 
Number of classes of medications 1.97 (1.04) 
Distance from hospital in kilometres 172.76 (327.06) 
 
In the sample there was a male preponderance with a mean (sd) chronological age of 
11.8 (4.75) years. The population was predominantly from an upper lower class 
background and a large majority were from a Hindu background. The recruited sample 
came from a far range of distance with a mean distance (sd) from the hospital of 
172.76 (327.06) kilometres. Around one third (36.6%) of the patients had a diagnosis 
of intellectual disability who were on medications for co morbidities. The majority of 
the sampled population (75.6%) did not have any co morbid illnesses. The mean (sd) 
duration of illness in months was 49.44 (41.17) and the mean duration (sd) of 
treatment was 20.37 (15.03). The mean number of classes of medicines was 1.9 (1.04). 
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6.2 Diagnostic Accuracy 
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Figure 1: ROC curve 
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Table 3: Summary of the diagnostic accuracy of the Score Card for the three month 
Predictive validity based on Clinician Rating Scale as the Gold standard. 
Variable scorecard_baseline 
Baseline Scorecard Total 
Classification variable CRS_di 
Sample size   41 
Positive group :  CRS_di = 
1 
24 
Negative group :  CRS_di = 
0 
17 
Disease prevalence (%) 58.5 
Area under the ROC curve (AUC)  0.714 
Standard Error
a
 0.0811 
95% Confidence interval
b
 0.552 to 0.844 
z statistic 2.644 
Significance level P (Area=0.5) 0.0082 
 
a
 DeLong et al., 1988 
 
b
 Binomial exact 
73 
 
Table 4: Criterion values and coordinates of the ROC curve 
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The sensitivity, specificity, likelihood ratios and different predictive values for 
different cut off points on the Vellore score card for medication adherence were tested 
against the dichotomised (based on the cut off of less than or equal to 5 as poor 
adherence) CRS which was considered the gold standard. Table 4 summarizes these 
results. A score of 0 was taken as the cut off score as it had a specificity of 100% 
making the score card a valid tool to predict non adherence. However its sensitivity 
was only 8.33% at this cut off. The area under curve (AUC) in the ROC of the score 
card was 0.714 (z is 2.644, p=0.0082).as noted in figure 1. 
 
6.3 Reliability 
 
Table 5: Test –retest reliability of the Score Card 
 
Intraclass 
Correlation
a
 
95% Confidence Interval  
Lower 
Bound 
Upper Bound P value 
Test-retest 
reliability 
0.51 -1.44 0.90 0.18 
a
=Two-way mixed effects model where people effects are random and measures 
effects are fixed. 
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Table 6: Inter-rater reliability of the Score Card 
 
a
=Two-way mixed effects model where people effects are random and measures 
effects are fixed. 
 
The test retest reliability and the inter rater reliability were studied to assess the 
reproducibility of the score card and the ICC was respectively 0.51 (p=0.18) and 0.77 
(0.07). According to Halgren et al the ICC scores for inter rater reliability is excellent 
 
 Intraclass 
Correlation
a
 
95% Confidence Interval 
P value 
Lower Bound Upper Bound 
Inter-rater 
reliability 
.767
c
 -.668 .967 0.07 
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6.4 Validity 
6.4.1 Divergent validity 
 
Divergent validity of the Score card against the Children‟s Sleep Habit Questionnaire 
(with and without resampling) 
 
Table 7 shows the divergent validity as calculated by correlating the score card with 
the child sleep habit questionnaire showed no significant association (r= - 0110, p = 
0.492). This proves that both the score card and the CSHQ diverge conceptually. 
 
 
Baseline Score 
Card 
CSHQ 
Confidence 
Intererval 
P value 
Baseline Score 
Card 
1 .110 95% .492 
CSHQ .110 1 95% .492 
6.4.2 Predictive validity 
There was no statistical difference between the scores of the vellore score card and the 
modified morisky‟s scale both of which were administered at follow up (chi square – 
1.143, p=1). However the kappa showed a case identification concordance of .1 
(kappa= .25, p=.285). 
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6.4.3Factor analysis 
Table 8: Total Variance Explained 
Component 
Initial Eigen values 
Extraction Sums of Squared 
Loadings 
Rotation 
Sums of 
Squared 
Loadings
a
 
Total 
% of 
Variance 
Cumulative 
% Total 
% of 
Variance 
Cumulative 
% Total 
1 2.433 24.335 24.335 2.433 24.335 24.335 2.028 
2 1.787 17.865 42.200 1.787 17.865 42.200 1.986 
3 1.416 14.161 56.361 1.416 14.161 56.361 1.615 
4 1.172 11.722 68.083 1.172 11.722 68.083 1.272 
5 1.086 10.865 78.948 1.086 10.865 78.948 1.184 
6 .884 8.842 87.790     
7 .571 5.707 93.497     
8 .454 4.543 98.040     
9 .112 1.117 99.157     
10 .084 .843 100.000     
Extraction Method: Principal Component Analysis. 
a. When components are correlated, sums of squared loadings cannot be added to 
obtain a total variance. 
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Figure 2: Scree plot for  
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Table 9: Structure Matrix 
 
Component 
1 2 3 4 5 
Sex -.634 -.126 -.153 .412 .305 
Parents Illiteracy -.023 .147 -.052 .023 .893 
Parents Primary School 
Education 
.330 .551 -.241 .422 -.268 
Parents Middle School 
Education 
-.076 .239 .741 -.111 -.221 
Upper Middle SES .160 -.036 -.104 -.856 -.054 
Lower Middle SES .135 -.882 -.109 .275 -.090 
Upper Lower SES -.188 .873 .179 .260 .167 
Continuous Illness .843 -.091 -.420 -.125 -.269 
BPAD -.087 -.065 .866 .127 .133 
Depression .845 -.182 -.032 .058 .214 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser Normalization. 
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Figure 3: Component plot 
Factor validity of the score card was carried out using the extraction and rotation 
methods. Five different factors were identified. However the items were found to not 
clearly load into any specific pattern. This could be due to the inadequate sample. 
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7. Discussion 
 
The Vellore score card for adherence to medications is the first time that a measure has 
been used to attempt to predict medication non adherence in all patients. Currently 
existing measures aim to capture the problem after it has occurred leading to 
significant dysfunction, distress and added costs as has been discussed initially. This 
specific score card was devised following a previous study undertaken by another 
researcher who was looking into various factors linked with medication non adherence 
in children and adolescent population with psychiatric disorders.  
 
As has been well established medication adherence is a well known fact among 
children as much as it is in the adult population. Hence any relapse is a significant 
burden on the family as well as the nation‟s resources. In a developing country like 
India where resources are scarce to come by whether in terms of healthcare, financial 
or any other, it would be prudent to say that any method to cut short this menace would 
be welcome. And it is in this gap that the score card falls in place as a method of 
cutting short this problem. If the score card is able to accurately pick up the possible 
children who are going to be non adherent to medications, then specific strategies to 
deal with it can be initiated. Hence this current study attempted to validate the same 
score card. At present this study is an ongoing study and is yet to be completed.  
Majority of the sampled patients were boys, which was as expected. This could be due 
to the fact that boys are preferentially taken to the hospital for consultations versus a 
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girl child. There may be other reasons such as the boy child being expected to be the 
income generator for the family in the future. Also the fact that, in the case of a girl 
child the stigma of having a mental illness could greatly affect the future marriage 
prospects and hence they would be not be brought to the hospital for such fears may be 
considered.  
 
Most of the patients were from a upper lower socioeconomic status family which is 
consistent with the location as well as the overall financial situation of the country. 
The patients had come from far ranging places which included far extreme places of 
the country and even neighbouring foreign nations. This could be due to the reason 
that the hospital where the study was conducted was a premier referral institute which 
targeted not just the immediate surrounding areas. Also the fact that the health care 
resources of the country not being well developed, the need to travel far to access 
quality health care is well understood. 
 
The majority of the patients were from a Hindu background which was also consistent 
with the sociodemographic profile of the country. Most parents were educated up to 
high school and belonged mostly to a nuclear family followed by a joint family. 
 
About one third of the patients were having intellectual disability. Schizophrenia, 
depression, bipolar disorders and OCD were the next most common diagnoses. The 
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other diagnoses included acute psychosis, adjustment disorder, ADHD and autism. 
This range of illnesses covered could give a better view of the problem as there was no 
undue focus on any one illness. Also the majority of the sampled patients, which was 
about 75% did not have any co morbid illnesses which again could show the effect of 
how a single illness can have in the case of medication adherence. 
 
In comparison to the gold standard which was the clinician rating scale (CRS) the cut 
off for the Vellore score card was considered at 0. This gave a specificity of 100% as 
against a sensitivity of 8.33%. This was done as the tool was designed to be a highly 
specific tool to predict non adherence and be used to devise or implement specific 
strategies in such children. In a resource strapped country this would help divert the 
focus to only such patients who would require this and prevent wasting precious 
resources in others who were less likely to do so. 
 
As was expected the measures of divergent validity which was the child sleep habit 
questionnaire was shown to have no correlation with the Vellore score card for 
medication adherence. This shows that the two scales are unrelated and measuring 
different constructs. 
 
According to Halgren et al various ranges of ICC value have been classified for inter 
rater reliability (108). According to them values that fall lesser than .40 are poor while 
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fair and good for values between .40 and .59 as well as .60 and .74 respectively. Those 
values that fall between .75 and 1.0 are deemed to be excellent. From this standard the 
Vellore score card had excellent inter rater reliability. 
 
However in the case of test retest reliability; Weir has commented in his review article 
that it is difficult to comment on classifying the reference ranges of the same using 
ICC (109). He commented that universal standards for test score reliability may not be 
feasible as it would also depend on the kind of method used to derive the value and 
also the ICC would also depend upon the variability in the data. And so in the event of 
low subject variability the ICC values could be suppressed. Also the socioeconomic 
status is a factor that can change by drop in income or change in profession of the 
parents. And hence this also could explain the reason as to why the test retest 
reliability was low.  Hence we choose to not consider the ICC of test retest reliability 
of the Vellore score card as significant. 
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8. Strengths and limitations 
 
8.1 Strengths 
 
This is the first time that a study is attempting to develop a predictive tool for 
medication adherence. Also this tool has been developed specifically for non-
adherence to medications in children and adolescents with psychiatric medications. 
The study does not focus onto any particular psychiatric disorder and rather includes 
all possible disorders. 
 
8.2Limitations 
 
We observed the following limitations to our study. 
 
The current results are based on the limited sample size and hence cannot be used to 
finally conclude. As the study will be continued, it is to be seen n the future whether 
there is any significant result that may occur. 
 
Also the score card currently uses mostly non modifiable factors and this may limit its 
application as there may be other factors that can be linked to medication adherence 
which may also have some predict value. This may need to be looked into further. 
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Currently the reference standards that are being used as gold standard, namely the 
Clinician rating scale (CRS) for the comparison are measures that are not specific to 
psychiatric disorders. This may also be a possible area of concern. 
 
Generalisabilty of the study is also in question as the scales used are not validated in 
our setting, and the study was done in a limited sample size 
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9. Conclusions 
 
A measure to capture the problem of medication adherence before it happens is truly 
the need of the hour. This study aims to fill in that void by validating a recently 
developed score card that aims to predict medication non adherence in children and 
adolescents with medications for psychiatric disorders. The study compared the score 
card with the reference standard of Clinician Rating Scale and derived a cut off score 
card with 100% specificity so as to accurately predict non adherence to medications 
and allow appropriate interventions to be put in place prior to the onset of the problem 
and thereby reduce the associated problems of relapse, loss of resources etc. this 
becomes especially true in a country such as India were finances and access to health 
care is limited for a majority of patients. The study found the score card to have good 
interrater reliability and fair test retest reliability. However the predictive accuracy was 
not significant. This could be due to the fact that the study is yet to be completed and 
with completion the results could very well turn out to be significant. 
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Participant Information Sheet 
Department of Child and Adolescent Psychiatry 
Christian Medical College Hospital 
 
Study Title:  
NON ADHERENCE IN CHILDREN AND ADOLESCENTS WITH PSYCHIATRIC DISORDERS: 
VALIDATION OF A NEWLY DEVELOPED SCORE CARD  
 
Children and adolescents with different psychiatric disorders are prescribed 
medications which some of them do not take regularly. This can affect their long term 
improvement and recovery from the illness. It is important to know the reasons why 
they are not taking medications. This knowledge will help us to identify those children 
who might fail to take medicines and prevent this. A score card has been newly 
developed to predict non adherence. This will help in putting into practice relevant 
measures to prevent or limit the occurrence of non adherence. You are being 
requested to participate in this study.  
 
If you take part what will you have to do?  
 
If you agree to participate in this study, you will be interviewed by the doctors 
conducting the study. These questions will cover various aspects of taking 
medications. No additional procedures or blood tests will be conducted for this study.  
 
Can you withdraw from this study after it starts?  
 
Your participation in this study is entirely voluntary and you are also free to decide to 
withdraw permission even after initial consent to participate in this study. Not 
participating in this study will not affect your usual treatment at this hospital in any 
way.  
 
Will your personal details be kept confidential?  
 
The results of this study will be published in a medical journal but you or child will not 
be identified by name in any publication or presentation of results.  
 
If you have any further questions, please ask:  
Dr Sony Mathews Lukose or Dr Paul S S Russell or Dr Priya Mammen,  
Child and Adolescent Unit, Department of Psychiatry, CMC, Bagayam,  
Vellore, Tamil Nadu  
Phone no: 0416 2284307  
E-mail: childpsych@cmcvellore.ac.in 
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Informed Consent to Participate in a Research Study 
 
1. Study Title: MEDICATION NON-ADHERENCE IN CHILDREN AND 
ADOLESCENTS WITH PSYCHIATRIC DISORDERS: PREDICTIVE 
ACCURACY, VALIDITY AND RELIABILITY OF A NEWLY DEVELOPED 
SCORE CARD.  
 
Study Number: ____________  
Subject’s Initials: ___________  
Subject’s Name: _________________________________________  
Date of Birth / Age: ___________________________  
(Subject)  
 
(i) I confirm that I have read and understood the information sheet dated 
____________ for the above study and have had the opportunity to ask questions. [ ]  
 
(ii) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ]  
 
(iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor‟s 
behalf, the Ethics Committee and the regulatory authorities will not need my 
permission to look at my health records both in respect of the current study and any 
further research that may be conducted in relation to it, even if I withdraw from the 
trial. I agree to this access. However, I understand that my identity will not be revealed 
in any information released to third parties or published. [ ]  
 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s). [ ]  
 
(v) I agree to take part in the above study. [ ]  
 
Signature (or Thumb impression) of the Subject/Legally Acceptable  
 
Date: _____/_____/______  
 
Signatory‟s Name: _________________________________ Signature: 
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Or  
Representative: _________________  
Date: _____/_____/______  
Signatory‟s Name: _________________________________  
Signature of the Investigator: ________________________  
Date: _____/_____/______  
Study Investigator‟s Name: _________________________  
Signature (or) thumb impression of the Witness: ___________________________  
Date: _____/_____/_______  
Name and Address of the Witness: ________________________________________ 
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Participant Information Sheet for Children 
Department of Child and Adolescent Psychiatry 
Christian Medical College Hospital 
 
 
Study Title: NON ADHERENCE IN CHILDREN AND ADOLESCENTS WITH 
PSYCHIATRIC DISORDERS: VALIDATION OF A NEWLY DEVELOPED 
SCORE CARD 
I am Dr Sony Mathews Lukose from Christian Medical College. Children and 
teenagers with different psychiatric illnesses are prescribed medications which some of 
them do not take regularly. This is called as non adherence. This can affect their long 
term improvement and recovery from the illness. It is important to know the reasons 
why they are not taking medications. This knowledge will help us to identify those 
children who might fail to take medicines and prevent this. I am doing a study to find 
out if a particular test that we have created is able to say in advance if a child is likely 
to no take his medications as advised by the doctor. We are asking you to take part in 
the research study because knowing the answer to this question will be helpful in 
identifying such children and  
For this research, we will ask you a few simple questions regarding your medication 
habits as well as your sleep habits. We will keep all your answers private, and will not 
show them to anyone else.  Only people working on the study will see them. 
We don‟t think that any big problems will happen to you as part of this study. Also 
there will be no blood tests. You only have to answer a few simple questions. Also, 
you can feel good about helping us to find an answer to this problem and have a part in 
helping other children. 
You do not have to be in this study if you do not want to. You won‟t get into any 
trouble for saying no. And even if you say yes, you may stop being in the study at any 
time. Your parent(s)/guardian(s) were already asked if it is OK for you to be in this 
study.  Even if they say it‟s OK, it is still your choice whether or not to take part.  You 
can ask any questions you have, now or later.  If you think of a question later, you or 
your parents can contact me at 
Dr Sony Mathews Lukose or Dr Paul S S Russell or Dr Minju K A or Dr Shonima  
Child & Adolescent Unit, Department of Psychiatry, CMC, Bagayam,  Vellore, Tamil 
Nadu, Phone : 0416 2284307; E-mail:  childpsych@cmcvellore.ac.in 
 
Sign this form only if you: 
1. have understood what you will be doing for this study, 
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2. have had all your questions answered. 
3. have talked to your parent(s)/legal guardian about this project. 
4. agree to take part in this research. 
 
 
_____________________________________________________________________Your 
Signature                   Name              Date 
______________________________________ 
Name of Parent(s) or Legal Guardian(s) 
_______________________________________________________________________ 
Researcher explaining study 
Signature                                           Name    Date  
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Serial No:  
 
1. Name of the patient:  
2. Hospital No:  
3. Age  
4. Gender  
5. Contact details of primary caregiver(telephone and postal address)  
6. Education of primary caregiver  
7. Occupation of primary caregiver  
8. Family income per month (in Rs)  
9. Distance from the hospital (in kms)  
10.  Type of the illness  
11.  Duration of the disorder (in days)  
12.  Nature of the disorder (relapsing/ continuous) (from data sheet)  
13.  Presence or absence of co-morbidities (from data sheet)  
14.  Years of training in Psychiatry (in years)  
15.  Change of therapist (from data sheet) 
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 Vellore Score Card for Adherence to Medication (Vellore SCAM)  
Predictive factor  Score  
Boys  3  
Illiterate  -0.75  
Primary School Education  -1.75  
Middle School Education  -2.25  
Occupation of parent  
SES  
Upper middle  
Lower middle  
Upper lower  
-0.75  
-10.5  
-3  
Continuous nature of illness  +7.5  
BPAD  
Depression  
-0.75  
+3  
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Morisky 8-Item Medication Adherence Questionnaire 
 
Question 
Patient 
Answer 
(Yes/No) 
Question      Patient Answer Score 
Yes/No  Y=1; N=0Y=1; 
N=0 
Do you sometimes forget to take your medicine? 
 
People sometimes miss taking their medicines for reasons other than forgetting. 
Thinking over the past 2 weeks, were there any days when you did not take your 
medicine? 
 
Have you ever cut back or stopped taking your medicine without telling your doctor 
because you felt worse when you took it? 
 
When you travel or leave home, do you sometimes forget to bring along your 
medicine? 
 
Did you take all your medicines yesterday? 
 
When you feel like your symptoms are under control, do you sometimes stop taking 
your medicine? 
 
Taking medicine every day is a real inconvenience for some people. Do you ever feel 
hassled about sticking to your treatment plan? 
 
How often do you have difficulty remembering to take all your medicine? 
__ A. Never/rarely       A =0; B-E=1 
__ B. Once in a while 
__ C. Sometimes 
__ D. Usually 
__ E. All the time 
 
 
Total score 
 
Scores: >2 = low adherence 
1 or 2 = medium adherence 
0 = high adherence 
 
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-
reported measure of medication adherence. 
Med Care. 1986;24:67-74. 
113 
 
 
114 
 
 
 
 Name of Patient: ___________________________     Date form filled out:____________  
 
 
Child’s Sleep Habits Questionnaire (pre-school and school-aged children) 
The following statements are about your child‟s sleep habits and possible difficulties with 
sleep. Think about the past week in your child‟s life when answering the questions. If last 
week was unusual for a specific reason (such as your child had an ear infection and did not 
sleep well or the TV set was broken) choose the most recent typical week.  
Answer USUALLY if something occurs 5 or more times in a week.  
Answer SOMETIMES if it occurs 2-4 times in a week.  
Answer RARELY if something occurs never or 1 time during a week.  
Indicate whether or not the sleep habit is a problem by circling “Yes”, “No,” or “not 
applicable (N/A)”.  
Write in child‟s bedtime: _____________ Write in child‟s usual wake time: ____________  
Child‟s usual amount of sleep each night (no naps): _________hours and _________minutes  
Child‟s usual amount of 
sleep each day (naps): 
_________hours and 
_________minutes 1  
Usually  
(5-7)  
2  
Sometimes  
(2-4)  
3  
Rarely  
(0-1)  
Problem?  
1. Child goes to bed at 
the same time at night  
   Yes No N/A  
2. Child falls asleep 
alone in own bed  
   Yes No N/A  
3. Child falls asleep 
within 20 minutes 
after going to bed  
   Yes No N/A  
4. Child sleeps the 
right amount  
   Yes No N/A  
5. Child sleeps about 
the same amount each 
day  
   Yes No N/A  
6. Child wakes up by 
him/herself  
   Yes No N/A  
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PLEASE TURN OVER AND COMPLETE OTHER SIDE!!! Page 1 of 2 
 
Name of Patient: ___________________________ Date form filled out:____________  
 
 3 
Usually 
5-7) 
2 
Sometimes 
(2-4) 
1 
Rarely 
(0-1) 
Problem? 
9. Child falls asleep in parent‟s 
or sibling‟s bed  
   Yes No N/A  
10. Child struggles at bedtime  
(cries, refuses to stay in bed, 
etc.)  
   Yes No N/A  
11. Child needs parent in the 
room to fall asleep  
   Yes No N/A  
12. Child is afraid of sleeping 
alone  
   Yes No N/A  
13. Child sleeps too little     Yes No N/A  
14. Child is afraid of sleeping 
in the dark  
   Yes No N/A  
15. Child has trouble sleeping 
away from home  
(visiting relatives, vacation)  
   Yes No N/A  
16. Child moves to someone else‟s bed during the night  
(parent, sibling, etc.)  
17. Child awakens once 
during the night  
   Yes No N/A  
18. Child awakens more 
than once during the night  
   Yes No N/A  
Write the number of minutes a night waking usually lasts: _____________  
19. Child talks during 
sleep  
   Yes No N/A  
20. Child is restless and 
moves a lot during sleep  
   Yes No N/A  
21. Child sleepwalks 
during the night  
   Yes No N/A  
22. Child wets the bed at 
night  
   Yes No N/A  
23. Child grind teeth 
during sleep  
(your dentist may have 
told you this)  
   Yes No N/A  
24. Child awakens 
alarmed by a frightening 
dream  
   Yes No N/A  
25. Child awakens during 
night screaming, 
   Yes No N/A  
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sweating, and 
inconsolable  
26. Child snores loudly     Yes No N/A  
27. Child seems to stop 
breathing during sleep  
   Yes No N/A  
28. Child snorts and/or 
gasps during sleep  
   Yes No N/A  
29. Child wakes up in a 
negative mood  
   Yes No N/A  
30. Adults or siblings 
wake up child  
   Yes No N/A  
31. Child has difficulty 
getting out of bed in the 
morning  
   Yes No N/A  
32. Child takes a long 
time to become alert in 
the morning  
   Yes No N/A  
33. Child seems tired in 
the morning  
   Yes No N/A  
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